Compound Testing of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Using Multi-Well Microelectrode Arrays

Area of Science:

• Cardiovascular Electrophysiology
• Stem Cell Biology
• Pharmacology

Background:

• Cardiac action potential relies on precise ion channel function; disruptions cause arrhythmias.
• Traditional single-channel assays lack physiological relevance, leading to premature drug candidate rejection.
• Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) offer a more accurate model for cardiac physiology.

Purpose of the Study:

• To present a protocol for cultivating hiPSC-CMs on microelectrode array (MEA) systems.
• To outline a compound testing strategy for enhanced predictive power in safety pharmacology.
• To improve the assessment of drug effects on cardiac electrical activity.

Main Methods:

• Cultivation of hiPSC-CMs on parallelized microelectrode array (MEA) systems.
• Non-invasive recording and analysis of cardiac field action potentials.
• Real-time monitoring of cardiomyocyte electrical activity for compound testing.

Main Results:

• Established a protocol for hiPSC-CM culture on MEA systems.
• Demonstrated a strategic approach for predictive compound testing.
• Enabled enhanced analysis of electrophysiological properties.

Conclusions:

• hiPSC-CMs on MEA systems provide a physiologically relevant platform for drug safety assessment.
• This approach enhances the predictive power of cardiac safety pharmacology assays.
• Facilitates personalized medicine through patient-derived cardiac models.